Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Placebo-controlled Phase	STARTED	Placebo Then Apremilast 30mg BID	44
Placebo-controlled Phase	STARTED	Apremilast 30 mg BID Then Apremilast 30 mg BID	46
Placebo-controlled Phase	COMPLETED	Placebo Then Apremilast 30mg BID	41
Placebo-controlled Phase	COMPLETED	Apremilast 30 mg BID Then Apremilast 30 mg BID	46
Placebo-controlled Phase	NOT COMPLETED	Placebo Then Apremilast 30mg BID	3
Placebo-controlled Phase	NOT COMPLETED	Apremilast 30 mg BID Then Apremilast 30 mg BID	0
Active-treatment Phase	STARTED	Placebo Then Apremilast 30mg BID	41
Active-treatment Phase	STARTED	Apremilast 30 mg BID Then Apremilast 30 mg BID	46
Active-treatment Phase	COMPLETED	Placebo Then Apremilast 30mg BID	40
Active-treatment Phase	COMPLETED	Apremilast 30 mg BID Then Apremilast 30 mg BID	44
Active-treatment Phase	NOT COMPLETED	Placebo Then Apremilast 30mg BID	1
Active-treatment Phase	NOT COMPLETED	Apremilast 30 mg BID Then Apremilast 30 mg BID	2

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04057937/flow